Ambalal Sarabhai Enterprises Quarterly Results for Trading Insights
AMBALALSA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QSept 2025
Ambalal Sarabhai Enterprises Quarterly Results Key Highlights
- Revenue of ₹46 Cr in Sept 2025 (-30.3% vs Mar 2025, -4.2% vs Sept 2024)
- Net Profit of ₹-1 Cr in Sept 2025 (-133.3% vs Sept 2024)
- EBITDA of ₹2 Cr in Sept 2025
- Operating Margin of 1.0% in Sept 2025 (+4.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.07 in Sept 2025 (-75.0% vs Mar 2025)
Ambalal Sarabhai Enterprises Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 46 | 66 | 49 | 48 | 59 | -30.3% | -4.2% |
| Net Profit (₹ Cr) | -1 | 0 | 8 | 3 | 9 | - | - |
| EBITDA (₹ Cr) | 2 | 0 | 10 | 5 | 9 | - | - |
| EPS (₹) | -0.07 | -0.04 | 1.07 | 0.34 | 1.18 | - | - |
| Operating Margin (%) | 1.0% | -3.0% | 4.0% | 6.0% | 9.0% | - | - |
Ambalal Sarabhai Enterprises Share Price Trend Around Quarterly Results
Visualize Ambalal Sarabhai Enterprises's 1-year price movement across quarterly results — ideal for logging trades in Ambalal Sarabhai Enterprises share price
chart using Tickjournal. All values in ₹.
Related Pages for Ambalal Sarabhai Enterprises
Additional stock information and data for AMBALALSA
Revenue Trend (₹ Cr)
Sept 2024
48
Jun 2025
49
Mar 2025
66
Sept 2025
46
Net Profit Trend (₹ Cr)
Sept 2024
3
Jun 2025
8
Mar 2025
0
Sept 2025
-1
Operating Margin Trend (%)
Sept 2024
6.0%
Jun 2025
4.0%
Mar 2025
-3.0%
Sept 2025
1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Ambalal Sarabhai Enterprises quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores